Navigation Links
Blue Dye Test Alternative Boosts Production Yields During Tough Times
Date:9/29/2009

The challenge of scarcer resources and climate change is driving up global demand for Sepha’s innovative leak-testing machines. The machines increase production yields and reduce waste in blisterpacking, sachets and pouches across a wide range of manufacturing sectors including pharmaceutical, medical, health, food & drink and offer an affordable yet effective blue dye test alternative.

Belfast (Vocus) September 29, 2009 -- Innovative leak testing equipment from Sepha provides a non-destructive blue dye test alternative that can save money and reduce waste by increasing production yields. As global manufacturers strive for lower SKU’s and greater cost efficiencies during tough economic times, the company says the need for these machines are at an all-time high because they enable product to be placed back on the production line.

PakScan from Sepha is a non-destructive leak testing machine for modern-day sachet and pouch packaging. Using state-of-the-art non contact technology at an affordable price, it is the best alternative to the messy blue dye test for a wide range of sectors from health and medical to food & drink.

Sepha Chief Executive Aubrey Sayers explains: “PakScan builds on the great success of our pharmaceutical leak-testing machine, BlisterScan, which is a non-destructive blue dye test alternative fo
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. Novel Alternative Approach to Inhibiting Insulin Growth Factor (IGF) May Provide New Treatment for Breast Cancer and Other Cancers
2. In vivo visualization of alternative splicing
3. Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data
4. Carrington Retains Milkie/Ferguson to Explore Financial Alternatives
5. A New Era in Cell Biology: German Company Develops Groundbreaking Alternative to Stem Cell Therapy
6. JIC Invests in Three New Alternative Energy Projects
7. Vermillion Retains ThinkPanmure to Assist in the Evaluation of Potential Strategic Alternatives
8. Alfacell Hires Advisors to Advance Strategic Alternatives
9. CPC of America, Inc. to Explore Strategic Alternatives; Appoints FTI Capital Advisors to Assess Potential Opportunities
10. Verenium Corporation to Speak at the Credit Suisse Alternative Energy Conference
11. ZhenSpa.com provides Spa Enthusiasts Affordable Alternatives for Expensive Spa Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blue Dye Test Alternative Boosts Production Yields During Tough Times
(Date:7/30/2015)... , ... July 30, 2015 , ... ... of a field clinical study of its canine osteoarthritis stem cell product, currently ... Therapeutics (Kansas City, KS) and will be marketed in the US by Aratana. ...
(Date:7/30/2015)... Ascendis Pharma A/S (Nasdaq: ASND ... TransCon technology to address significant unmet medical needs, ... Phase 2 study to evaluate the safety and ... treatment-naïve, pre-pubertal children with growth hormone deficiency, or ... the top-line results from our Phase 2 pediatric ...
(Date:7/30/2015)... ... July 30, 2015 , ... GEA's ... designed for continuous operation up to 1500 bar. The sanitary design gauge of ... preventing toxic contamination. , The Pony™ NS2006L homogenizer is an ideal solution for ...
(Date:7/29/2015)... -- US-Australian drug discovery company, Novogen Limited (ASX: NRT; ... to progressing its ground-breaking technology platforms to Phase 1 ... the Company delivers the best value for shareholders. ... said the Company currently had an extensive program of ... and academic partnerships and initiatives, and he was working ...
Breaking Biology Technology:VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10
... 5 BioSpecifics,Technologies Corp. (OTC Bulletin Board: BSTC), ... products, announced today that,it has signed an agreement ... future royalty obligations for Peyronie,s disease by buying ... payment., BioSpecifics has modified its previously announced ...
... to Expand Business Development Efforts, SALT LAKE ... company,focused on the development of molecular diagnostic and ... today that Joe Ross has,joined the executive management ... Initiatives., In this new role, Ross will ...
... BFRM ) today announced its financial results for the ... sales were $16.7,million for the quarter ended June 30, 2008 ... 2007, an increase of $1.3 million or 8.4%.,The net loss ... as,compared to a net loss of $4.9 million for the ...
Cached Biology Technology:BioSpecifics Technologies Corp. Buys Down Royalties for Peyronie's Disease 2Axial Biotech appoints new Vice President of Strategic Initiatives 2BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 2BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 3BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 4BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 5BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 6BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 7BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 8BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 9
(Date:6/24/2015)... This report provides market analysis of the ... It contains an analysis of the drivers, challenges, and ... from the short, medium, and long term perspective landscapes. ... and technology trends that currently, prevail in the market. ... to efficiently manage the increasing marine traffic and increasing ...
(Date:6/24/2015)... 22, 2015 Research ... of the "Huawei Ascend Mate 7 Fingerprint ... their offering. Huawei,s technological choice for ... direction than Apple,s and Samsung,s one. The Ascend ... by Fingerprint Cards, a main actor in capacitive ...
(Date:6/23/2015)... 2015   MedNet Solutions , an innovative ... spectrum of clinical research, is pleased to announce ... the company,s intuitive, flexible and affordable cloud-based eClinical ... Stevie® Award by the American Business Awards ... category.  The American Business Awards are considered the ...
Breaking Biology News(10 mins):Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2
... Elsevier, a world-leading provider of scientific, technical ... leading German scientist, Professor Dr. Manfred T. Reetz ... Meerwein Research Professor at Philipps-Universitt, Marburg, has been ... Creativity in Organic Chemistry. The Executive ...
... demonstrated how a species of flatworm overcomes the ageing ... in the Proceedings of the National Academy of ... the Biotechnology and Biological Sciences Research Council (BBSRC) and ... the possibilities of alleviating ageing and age-related characteristics in ...
... A striking discovery in the study of human genetics ... on EurekAlert! in 2011. Researchers found that part of ... that they interbred with early human populations. Breakthroughs ... in zoology, psychology, and astrobiology, were also featured in ...
Cached Biology News:Leading German Researcher awarded Elsevier's 2011 Tetrahedron Prize 2Immortal worms defy aging 2Immortal worms defy aging 3Story on human genetic origins is one of EurekAlert!’s most-visited releases in 2011 2Story on human genetic origins is one of EurekAlert!’s most-visited releases in 2011 3Story on human genetic origins is one of EurekAlert!’s most-visited releases in 2011 4
ANTI S. GROUP AG:H...
This kit only detects beta-galactosidase activity at pH 6 in cultured cells andtissue sections. Beta-galactosidase activity at pH 6 ispresent only in senescent cells, and is not found inpresenescent...
2,4,6, Trinitrophenyl hapten is conjugated to lipopolysaccharide (LPS)....
... need to make your strain of cells competent ... for preparing competent cells are comprehensive and customized ... service offers: High transformation efficiencies ... Quality control performance testing Great ...
Biology Products: